JACC 82(9):833955 Rangaswami J, Bhalla V, de Boer IH, Staruschenko A, Sharp JA, Singh RR et al (2020) Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association
The American Medical Association recognized obesity as a chronic disease in 2013, but many people still do not view it that way, Hernandez said
It's not a weight-loss ingredient on its own, but deficiency is linked to fatigue, which can undercut motivation to stay consistent with any weight-management routine
Some of the potential side effects of GLP-1 patches might include: feeling or being sick diarrhoea headaches heartburn skin reactions Some people choose to stop using GLP-1 injections in favour of these patches, perhaps because of the cost difference or reported success stories, but this is not recommended
So far only one oral GLP-1 has appeared on the market, in 2019